PolarityTE Inc PTE:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/24/22 EDT
1.67quote price arrow up+0.09 (+5.70%)
Volume
229,032
52 week range
1.51 - 28.50
Loading...
  • Open1.60
  • Day High1.85
  • Day Low1.60
  • Prev Close1.58
  • 52 Week High28.50
  • 52 Week High Date06/24/21
  • 52 Week Low1.51
  • 52 Week Low Date06/23/22

Key Stats

  • Market Cap6.71M
  • Shares Out4.02M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-88.62

KEY STATS

  • Open1.60
  • Day High1.85
  • Day Low1.60
  • Prev Close1.58
  • 52 Week High28.50
  • 52 Week High Date06/24/21
  • 52 Week Low1.51
  • 52 Week Low Date06/23/22
  • Market Cap6.71M
  • Shares Out4.02M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-88.62

RATIOS/PROFITABILITY

  • EPS (TTM)-5.04
  • P/E (TTM)-0.33
  • Fwd P/E (NTM)-0.30
  • EBITDA (TTM)-31.083M
  • ROE (TTM)-71.74%
  • Revenue (TTM)5.44M
  • Gross Margin (TTM)51.40%
  • Net Margin (TTM)-304.42%
  • Debt To Equity (MRQ)8.87%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date01/19/2016
  • Div Amount0.3355
  • Split Date-
  • Split Factor-

Latest On PolarityTE Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
PolarityTE, Inc. is a biotechnology company. The Company is focused on developing regenerative tissue products and biomaterials. It also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need...
Peter Cohen
Independent Chairman of the Board
Richard Hague
President, Chief Executive Officer
Jacob Patterson
Interim Chief Financial Officer
Cameron Hoyler J.D.
General Counsel, Secretary, Executive Vice President Corporate Development and Strategy
Address
1960 S. 4250 West
Salt Lake City, UT
84104
United States

Top Peers

SYMBOLLASTCHG%CHG
HSTO
Histogen Inc
2.30-0.04-1.71%
PULM
Pulmatrix Inc
4.49-0.09-1.97%
HTGM
HTG Molecular Diagnostics Inc
0.5445+0.0195+3.71%
TTNP
Titan Pharmaceuticals Inc
0.5851+0.0051+0.88%
YMTX
Yumanity Therapeutics Inc
1.75UNCHUNCH